Procept Biorobotics
PRCT
271 hedge funds and large institutions have $3.07B invested in Procept Biorobotics in 2025 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 121 increasing their positions, 82 reducing their positions, and 40 closing their positions.
91% more call options, than puts
Call options by funds: $15.5M | Put options by funds: $8.09M
48% more repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 82
4.36% more ownership
Funds ownership: 92.01% → 96.38% (+4.4%)
5% more capital invested
Capital invested by funds: $2.94B → $3.07B (+$132M)
3% less funds holding
Funds holding: 279 → 271 (-8)
15% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 40
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$48M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$40.1M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$31.8M |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$24.9M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$22.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$23.9M |
| 2 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$23.9M |
| 3 |
D.E. Shaw & Co
New York
|
-$20.1M |
| 4 |
Millennium Management
New York
|
-$19.9M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$19.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AAP
301
Arax Advisory Partners
Denver,
Colorado
| – | -$2.21K | -38 | Closed |
|
|
WA
302
WPG Advisers
Baltimore,
Maryland
| – | -$2.16K | -37 | Closed |
|
|
DRP
303
Decker Retirement Planning
Levi,
Utah
| – | -$1.75K | -30 | Closed |
|
|
MPWT
304
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| – | -$1.75K | -30 | Closed |
|
|
QCG
305
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$1.63K | -28 | Closed |
|
|
GWM
306
Geneos Wealth Management
Englewood,
Colorado
| – | -$4.54K | -26 | Closed |
|
|
CA
307
Continuum Advisory
Eagle,
Idaho
| – | -$699 | -12 | Closed |
|
|
HNB
308
Huntington National Bank
Columbus,
Ohio
| – | -$641 | -11 | Closed |
|
|
TCM
309
TD Capital Management
Memphis,
Tennessee
| – | -$641 | -11 | Closed |
|
310
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$466 | -8 | Closed |
|
|
C
311
Covestor
London,
United Kingdom
| – | -$57 | -1 | -33% |
|
PRCT Hedge Fund Activity: Q2 2025 in Review
271 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q2 2025, worth a combined $3.07B — up 4.5% from $2.94B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of PRCT and 34 opened new positions — a net loss of 6 holders — while 82 trimmed existing stakes and 121 added.
The largest buyer was Westfield Capital Management, adding an estimated $48M. The largest seller was Fidelity Investments, cutting an estimated $23.9M.
- 271 institutional investors held Procept Biorobotics (PRCT) as of Q2 2025, down from 279 in Q1 2025.
- Funds reported $3.07B of Procept Biorobotics stock for Q2 2025, up 4.5% quarter-over-quarter.
- 34 funds opened new Procept Biorobotics positions in Q2 2025 and 40 closed out, a net change of -6 holders.
- The largest Procept Biorobotics buyer in Q2 2025 was Westfield Capital Management, an estimated $48M added.
- The largest Procept Biorobotics seller in Q2 2025 was Fidelity Investments, an estimated $23.9M sold.
Based on aggregated 13F filings for Q2 2025.